Genocea Biosciences (GNCA) Tops Q2 EPS by 8c

Genocea Biosciences (NASDAQ: GNCA) reported Q2 EPS of ($0.43), $0.08 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $115 thousand versus the consensus estimate of $50 thousand.

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BWS Financial Downgrades Inter Parfums (IPAR) to Sell
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)